Cost-Effectiveness Analysis of Antiviral Therapy for Untreated Minimally Active Chronic Hepatitis B to Prevent Liver Disease Progression

Antiviral therapy (AVT) for chronic hepatitis B (CHB) can prevent liver disease progression. Because of its stringent reimbursement criteria, significant numbers of patients with untreated minimally active (UMA)-CHB exist, although they are still subject to disease progression. We thus performed a c...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Hankil, Kim, Beom Kyung, Jang, Sungin, Ahn, Sang Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889372/
https://www.ncbi.nlm.nih.gov/pubmed/33600103
http://dx.doi.org/10.14309/ctg.0000000000000299

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889372/
https://www.ncbi.nlm.nih.gov/pubmed/33600103
http://dx.doi.org/10.14309/ctg.0000000000000299

Ejemplares similares